
AbCellera Biologics ABCL
€ 12.21
0.36%
Land |
|
IPO-Jahr |
2020 |
Branche |
Pharmaeinzelhändler |
Börse |
NASDAQ GLOBAL |
Anteile |
299 M |
Marktkapitalisierung |
$ 4.1 B |
EBITDA (LTM) |
$ -199 M |
P/E (LTM) |
-23.326531 |
P/S (LTM) |
45.445399 |
EPS (LTM) |
-0.49 |
Andere Aktien der Branche "Pharmaeinzelhändler"
| Name | Preis | % 24h | Marktkapitalisierung | Börse | Land | |
|---|---|---|---|---|---|---|
|
Ionis Pharmaceuticals
IONS
|
$ 43.54 | 0.13 % | $ 6.97 B | Nasdaq Global Select Market,SPB | ||
|
Iovance Biotherapeutics
IOVA
|
$ 14.22 | 0.6 % | $ 5.08 M | Nasdaq Global Market,SPB | ||
|
Innate Pharma S.A.
IPHA
|
$ 1.56 | 0.63 % | $ 140 M | Nasdaq Global Select Market | ||
|
Ironwood Pharmaceuticals
IRWD
|
$ 3.64 | 0.27 % | $ 589 M | Nasdaq Global Select Market | ||
|
Inventiva S.A.
IVA
|
$ 3.56 | 2.89 % | $ 213 M | Nasdaq Global Market | ||
|
Jaguar Health
JAGX
|
$ 3.66 | 1.01 % | $ 8.54 M | Nasdaq Capital Market | ||
|
Jazz Pharmaceuticals plc
JAZZ
|
$ 235.67 | 1.14 % | $ 14.4 B | Nasdaq Global Select Market | ||
|
Johnson & Johnson
JNJ
|
$ 256.03 | 0.03 % | $ 616 B | NYSE,SPB | ||
|
Kala Pharmaceuticals
KALA
|
$ 0.39 | 0.86 % | $ 3.18 M | Nasdaq Global Select Market | ||
|
Kamada Ltd.
KMDA
|
$ 8.31 | 1.34 % | $ 479 M | Nasdaq Global Select Market | ||
|
Kiniksa Pharmaceuticals, Ltd.
KNSA
|
$ 75.79 | 0.76 % | $ 5.62 B | Nasdaq Global Select Market | ||
|
Kodiak Sciences
KOD
|
$ 94.45 | 3.86 % | $ 5.03 B | Nasdaq Global Market,SPB | ||
|
Karyopharm Therapeutics
KPTI
|
$ 0.8 | 1.51 % | $ 8.75 K | Nasdaq Global Select Market | ||
|
Keros Therapeutics
KROS
|
$ 11.36 | 0.89 % | $ 423 M | Nasdaq Global Select Market | ||
|
Krystal Biotech
KRYS
|
$ 322.28 | 0.18 % | $ 9.33 B | Nasdaq Global Market,SPB | ||
|
Kura Oncology
KURA
|
$ 10.65 | 0.09 % | $ 934 M | Nasdaq Global Select Market | ||
|
Kymera Therapeutics
KYMR
|
$ 107.39 | 0.35 % | $ 9.07 B | Nasdaq Global Market | ||
|
Kazia Therapeutics Limited
KZIA
|
$ 9.27 | 0.42 % | $ 141 M | Nasdaq Global Select Market | ||
|
Lineage Cell Therapeutics
LCTX
|
$ 0.93 | 2.89 % | $ 214 M | NYSE American | ||
|
Legend Biotech Corporation
LEGN
|
$ 18.57 | 0.21 % | $ 6.85 B | Nasdaq Global Select Market | ||
|
Ligand Pharmaceuticals Incorporated
LGND
|
$ 302.96 | 0.07 % | $ 5.86 B | Nasdaq Global Select Market,SPB | ||
|
Longeveron
LGVN
|
$ 2.58 | 0.77 % | $ 45.3 B | Nasdaq Global Select Market | ||
|
Eli Lilly and Company
LLY
|
$ 1 142.85 | 0.34 % | $ 1.03 T | NYSE,SPB | ||
|
Lipocine
LPCN
|
$ 2.05 | 0.97 % | $ 11.2 M | Nasdaq Global Select Market | ||
|
Liquidia Corporation
LQDA
|
$ 28.64 | 2.32 % | $ 2.46 B | Nasdaq Capital Market | ||
|
Larimar Therapeutics
LRMR
|
$ 2.96 | 1.75 % | $ 246 M | Nasdaq Global Market | ||
|
Lantern Pharma
LTRN
|
$ 0.86 | 2.0 % | $ 9.37 M | Nasdaq Global Select Market | ||
|
Lexicon Pharmaceuticals
LXRX
|
$ 1.82 | 0.82 % | $ 661 M | Nasdaq Global Select Market | ||
|
Mustang Bio
MBIO
|
$ 0.47 | 1.16 % | $ 2.31 M | Nasdaq Global Market | ||
|
Moleculin Biotech
MBRX
|
$ 0.49 | 0.42 % | $ 580 K | Nasdaq Global Select Market | ||
|
Seres Therapeutics
MCRB
|
$ 2.94 | 0.34 % | $ 26 M | Nasdaq Global Select Market | ||
|
Madrigal Pharmaceuticals
MDGL
|
$ 499.4 | 0.1 % | $ 11.2 B | Nasdaq Global Select Market,SPB | ||
|
Mesoblast Limited
MESO
|
$ 14.08 | 2.55 % | $ 17 B | Nasdaq Global Select Market | ||
|
MacroGenics
MGNX
|
$ 3.58 | 0.14 % | $ 226 M | Nasdaq Global Select Market | ||
|
MeiraGTx Holdings plc
MGTX
|
$ 10.79 | 1.22 % | $ 868 M | Nasdaq Global Select Market | ||
|
Mirum Pharmaceuticals
MIRM
|
$ 82.93 | 0.03 % | $ 4.16 B | Nasdaq Global Select Market | ||
|
Milestone Pharmaceuticals
MIST
|
$ 0.81 | 0.25 % | $ 86.1 M | Nasdaq Global Select Market | ||
|
MannKind Corporation
MNKD
|
$ 3.8 | 1.28 % | $ 1.16 B | Nasdaq Global Market | ||
|
MediciNova
MNOV
|
$ 1.78 | 9.2 % | $ 87.3 M | Nasdaq Global Market | ||
|
Monopar Therapeutics
MNPR
|
$ 77.97 | 0.03 % | $ 578 M | Nasdaq Global Select Market | ||
|
Mereo BioPharma Group plc
MREO
|
$ 0.38 | 3.52 % | $ 303 M | Nasdaq Global Select Market | ||
|
Merck & Co.
MRK
|
$ 144.3 | 0.34 % | $ 361 B | NYSE,SPB | ||
|
Marker Therapeutics
MRKR
|
$ 1.05 | 0.95 % | $ 16.1 M | Nasdaq Global Market | ||
|
Moderna
MRNA
|
$ 190.01 | 0.57 % | $ 73.9 B | Nasdaq Global Select Market,SPB | ||
|
Maravai LifeSciences Holdings
MRVI
|
$ 7.9 | 5.33 % | $ 1.14 B | Nasdaq Global Select Market | ||
|
Matinas BioPharma Holdings
MTNB
|
$ 2.64 | 9.09 % | $ 14.5 M | NYSE American | ||
|
Neurocrine Biosciences
NBIX
|
$ 143.18 | 1.76 % | $ 14.2 B | Nasdaq Global Select Market,SPB | ||
|
NuCana plc
NCNA
|
$ 1.09 | 4.19 % | $ 12.2 B | Nasdaq Global Select Market | ||
|
Minerva Neurosciences
NERV
|
$ 3.28 | 1.55 % | $ 27.8 M | Nasdaq Global Market | ||
|
Nektar Therapeutics
NKTR
|
$ 43.58 | 2.2 % | $ 735 M | Nasdaq Global Select Market,SPB |